openPR Logo
Press release

Cardiac Biomarkers Market Global Research Analysis Report and Clinical Outlook 2021 to 2030

12-02-2021 04:26 PM CET | Health & Medicine

Press release from: Nextmsc

Cardiac Biomarkers Market Global Research Analysis Report

The Global Cardiac Biomarkers Market size was valued at USD 8.42 billion in 2019 and is predicted to reach USD 28.29 billion by 2030, with a CAGR of 11.6% from 2020-2030.

The adoption of cost-effective Cardiac Point of Care (PoC) testing kits that offer quick results with higher accuracy are gaining momentum over the period, thereby supplementing the growth of cardiac biomarkers market.

Request sample copy of this report at:-

https://www.nextmsc.com/cardiac-biomarkers-market/request-sample

Top Companies: Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, BioMerieux, Beckman Coulter, Randox laboratories, and Thermo Fisher Scientific

Market Dynamics and Trends

According to the data World Health Organization, more than 17.9 million people worldwide, die of Cardiovascular diseases (CVDs), every year. This scenario consequently escalates the demand for advanced healthcare facilities that offer precise diagnostics, monitoring and treatments options for patients suffering from CVDs, thereby propagating the growth of global cardiac biomarkers market.

Furthermore, benefits offered by cardiac biomarkers such as, fast and precise depictions of heart failures after the one-set of chest pain, and high sensitivity of biomarkers test-kit offering precise results; are expected to propagate the growth of global cardiac biomarkers market.

However, limited use of biomarkers test in specific cases, and risk of skeletal injury are the limiting factors expected to slow down the growth of cardiac biomarkers market.

Moreover, multiple options to formulate different combinations for cardiac biomarkers testing, manufacturers offering various customized solutions, and increasing investment in the R&D activities for new clinical research by government and non-government authorities, are the factors anticipated to propel the growth of global cardiac biomarkers market in coming future.

Inquire for discount offer at:-

https://www.nextmsc.com/cardiac-biomarkers-market/inquire-before-buying

Market Segmentations and Scope of the Study:

The global cardiac biomarkers market share has been analyzed based on type, application, location of testing and geography.

Based on product type, the cardiac biomarkers market is segmented into Myocardial muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs), Troponins (T and I), or NT-proBNP, Ischemia Modified Albumin (IMA), and Others. Based on application, the market is categorized into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others. Based on location of testing, the market is divided into Point of care testing and Laboratory testing. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America dominated the global cardiac biomarkers market, and is expected to maintain this trend throughout the forecast period, accounting for the highest market share. This is attributed to well-established healthcare infrastructures and medical laboratories. Moreover, increasing incidences of CVDs due to sedimentary lifestyles, and adoption of PoC gaining momentum, are the factors expected to further propel the cardiac biomarkers market growth in this region.

Asia Pacific region is expected to grow substantially in the global cardiac biomarkers market, owing to increasing accessibility to healthcare facilities, higher prevalence of CVDs due constantly multiplying population, increasing medical tourism, and increasing awareness regarding treatment options.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Biomarkers Market Global Research Analysis Report and Clinical Outlook 2021 to 2030 here

News-ID: 2483415 • Views:

More Releases from Nextmsc

Home Automation Market 2022 | Size, Growth, Demand, Opportunities and Forecast 2030
Home Automation Market 2022 | Size, Growth, Demand, Opportunities and Forecast 2 …
The Home Automation Market size was valued at USD 84.33 billion in 2021 and is predicted to reach USD 210.15 billion by 2030 with a CAGR of 10.7% from 2022-2030. Home automation also known as smart home, is an automation system, which provides access to control appliances such as alarm systems, electrical outlets, lights, fans, and others, using a smartphone. In this system, the primary focus is on home
Packaging Robots Market Competitive Landscape, Key Players, Business Opportunities and Forecast 2022-2030
Packaging Robots Market Competitive Landscape, Key Players, Business Opportuniti …
The Packaging Robots Market size was valued at 4.02 billion in 2021 and is predicted to reach 8.60 billion by 2030 with a CAGR of 8.9% from 2022-2030. Packaging robots are designed to handle materials, seal & label, and move or pack goods among other tasks to enable products to be packaged. These robots are significantly flexible and easy to integrate into a workspace. When compared with manual processes, packaging
Automated Guided Vehicle (AGV) Market 2022 Future Development Status Recorded till 2030
Automated Guided Vehicle (AGV) Market 2022 Future Development Status Recorded ti …
The Automated Guided Vehicle Market size was valued at 4.02 billion in 2021 and is predicted to reach 8.66 billion by 2030 with a CAGR of 8.9% from 2022-2030. Automated guided vehicle is the material handling automated machines that are programmed to move carts, trays, and pallets in different warehousing and manufacturing facilities. The automation through automated guided vehicle (AGV) aids the requirement for material handling capacity, decreasing production time
ROS Based Robot Market predicted to reach 87.92 billion by 2030 with a CAGR of 8.4% from 2022-2030
ROS Based Robot Market predicted to reach 87.92 billion by 2030 with a CAGR of 8 …
The ROS Based Robot Market was valued at 42.69 billion in 2021 and is predicted to reach 87.92 billion by 2030 with a CAGR of 8.4% from 2022-2030. The Robot Operating System (ROS) is a set of software tools and libraries that enables the user to build robot applications. It is the collection of open-source software frameworks for robot software development. ROS in robots offers the services of an operating

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,